The New Mexico DPA office opened in 2000. Since then, we have helped enact a range of drug policy reforms through the legislative process. Our focus areas include:
DPA's New Mexico State Director, Emily Kaltenbach, chaired the city of Santa Fe's Municipal Drug Strategy Task Force. In February 2020, the task force released a report that provides a roadmap for the city to move forward with drug strategies that focus on public health and safety.
"Santa Fe is another example of bold municipal leadership. The work of the Santa Fe Municipal Drug Strategy Task Force demonstrates how cities can step up and implement innovative drug policies rooted in science, compassion, and public health. Even when the federal government fails to act, cities can.” - Emily Kaltenbach
Nearly three out of four New Mexicans approve of cannabis legalization. DPA is advocating at the state legislature for passage of legislation allowing the possession, use, and sale of marijuana. Join our Grow New Mexico campaign to legalize marijuana in the state.
DPA is committed to reducing the harms associated with drug use in New Mexico. Our priorities include expanding naloxone access, authorizing overdose prevention programs, expanding access to drug checking services, increasing Medication Assisted Treatment (MAT) access, and establishing a Heroin Assisted Treatment (HAT) pilot program.
Drug arrests have led to unprecedented levels of incarceration in New Mexico, especially for people of color. We advocate for municipal drug strategies that will move small towns and cities from criminal justice structures towards public health structures.
(505) 983-3277 ph
nm "at" drugpolicy.org